Lopid Patent Term Restoration and Fairness Act of 1987: Hearing Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, First Session, October 8, 1987, Volume 4U.S. Government Printing Office, 1988 - 350 pages |
From inside the book
Results 1-5 of 68
Page 41
... primary prevention study that was done several years ago , also a landmark study . On my right , Mr. Chairman , is Peter Hutt . I think he is known to a lot of you . He is former chief counsel of the Food and Drug Administration and is ...
... primary prevention study that was done several years ago , also a landmark study . On my right , Mr. Chairman , is Peter Hutt . I think he is known to a lot of you . He is former chief counsel of the Food and Drug Administration and is ...
Page 62
... primary heart attack prevention study in high - risk patients in Finland . " 1980 1981 1982 1983 1984 1985 1986 1987 Helsinki Heart 62.
... primary heart attack prevention study in high - risk patients in Finland . " 1980 1981 1982 1983 1984 1985 1986 1987 Helsinki Heart 62.
Page 63
... primary heart attack prevention study among 4,000 high - risk males . From a total of 23,600 eligible men from the Finnish Railway and Postal Services , 83 percent volunteered to participate . A series of medical screenings reduced the ...
... primary heart attack prevention study among 4,000 high - risk males . From a total of 23,600 eligible men from the Finnish Railway and Postal Services , 83 percent volunteered to participate . A series of medical screenings reduced the ...
Page 68
... Primary Prevention Trial . This trial begun in 1973 was reported in January 1984. It cost NHLBI an estimated 160 million dollars and involved almost 4,000 American hypercholesterolemic men , age 35-59 . It demonstrated conclusively for ...
... Primary Prevention Trial . This trial begun in 1973 was reported in January 1984. It cost NHLBI an estimated 160 million dollars and involved almost 4,000 American hypercholesterolemic men , age 35-59 . It demonstrated conclusively for ...
Page 69
... Primary Prevention Trial with Clofibrate ) . Many within FDA in fact wondered whether any new cholesterol lowering drugs should be approved until the efficacy of cholesterol lowering on CHD risk was proven . A compromise solution ...
... Primary Prevention Trial with Clofibrate ) . Many within FDA in fact wondered whether any new cholesterol lowering drugs should be approved until the efficacy of cholesterol lowering on CHD risk was proven . A compromise solution ...
Other editions - View all
Common terms and phrases
apolipoprotein Association atherosclerosis baseline bill blood Capsules cardiovascular cent Chairman changes cholesterol cholesterol levels cholestyramine clofibrate Committee concentrations coronary heart disease decrease diabetic diet dose Drug Administration dyslipidaemic effect of gemfibrozil elevated fatty acid composition FDA approval Finland follow-up Food and Drug Framingham gemfibrozil treatment glucose HDL-cholesterol Health heart attacks Helsinki Heart Study hypercholesterolaemia hypertension incidence increase ischaemic heart disease Journal KASTENMEIER Kaukola laboratory legislation lipid lowering Lipid Research Clinics lipid-lowering lipoprotein cholesterol lipoprotein lipase lipoprotein lipase activity Lithell long-term Lopid Lopid patent low density lipoprotein LRC-CPPT male Manninen market exclusivity metabolism mmol/l mortality myocardial infarction Parke-Davis patent extension patent term extension patients pharmaceutical Phase IV study placebo Primary Prevention Trial ratio reduction regulatory risk factors Royal Society safety serum cholesterol serum lipid significant Society of Medicine Subcommittee Table Term Restoration Act therapy treatment groups triglycerides Vessby VLDL Warner-Lambert Waxman-Hatch
Popular passages
Page 113 - A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity, J.
Page 113 - Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Page 291 - Kagan A.: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
Page 73 - I am a partner in the Washington, DC law firm of Covington & Burling. I have been asked to present testimony on patent term restoration.
Page 341 - Five-year findings of the Hypertension Detection and Followup Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 244 - For the purposes of paragraph (2)(B), the term "due diligence" means that degree of attention, continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
Page 67 - HL-07182 from the National Heart, Lung and Blood Institute of the National Institutes of Health, and by the American Heart Association, Indiana Affiliate, Inc.
Page 8 - Mr. BOUCHER. Thank you very much, Mr. Chairman. I want to commend you...